Dyslipidemia is the medical term for abnormal levels of fats (lipids) in your blood. Specifically, it refers to elevated cholesterol, elevated triglycerides, or low levels of HDL (the “good” cholesterol) that contribute to the development of atherosclerosis, the buildup of fatty plaques inside artery walls. It is not a single condition but an umbrella term covering several patterns of lipid imbalance.
The Lipid Markers Involved
A standard lipid panel measures four values, and dyslipidemia can involve one or more of them being out of range. LDL cholesterol is the primary driver of plaque buildup in arteries. Triglycerides are a type of fat your body uses for energy but stores in excess when you consume more calories than you burn. HDL cholesterol works in the opposite direction, helping remove cholesterol from your bloodstream. Total cholesterol is the sum of all cholesterol types circulating in your blood.
Clinicians increasingly pay attention to a fifth number: non-HDL cholesterol, which captures the cholesterol carried by all the particles that promote plaque formation, not just LDL. A large body of evidence now shows that non-HDL cholesterol is a better predictor of cardiovascular risk than LDL alone, particularly in people with high triglycerides or metabolic conditions like diabetes. You can calculate it yourself by subtracting your HDL number from your total cholesterol.
How Dyslipidemia Is Classified
Doctors categorize dyslipidemia into three patterns based on which lipids are elevated:
- Isolated hypercholesterolemia: only cholesterol is high
- Isolated hypertriglyceridemia: only triglycerides are high
- Mixed or combined hyperlipidemia: both cholesterol and triglycerides are high
Beyond this, dyslipidemia is classified as either primary or secondary. Primary dyslipidemia is genetic. It results from inherited mutations that cause your body to overproduce LDL or triglycerides, fail to clear them from the blood efficiently, or underproduce HDL. Familial hypercholesterolemia is the most well-known example. People with this condition can have LDL levels above 190 mg/dL from childhood, sometimes much higher.
Secondary dyslipidemia is caused by lifestyle factors, other medical conditions, or medications. In developed countries, the most common secondary cause is a sedentary lifestyle combined with excessive intake of calories, saturated fat, and trans fats. Diabetes, hypothyroidism, chronic kidney disease, liver disease, and heavy alcohol use also disrupt lipid metabolism. Certain medications, including some blood pressure drugs, steroids, and antiretroviral therapies, can raise cholesterol or triglycerides as a side effect. Smoking and anabolic steroids specifically lower HDL.
What Happens Inside Your Arteries
The reason dyslipidemia matters is its direct role in atherosclerosis. When there is too much LDL circulating in the blood, these particles penetrate the walls of arteries and become trapped. Once inside the artery wall, LDL particles become oxidized, triggering an immune response. White blood cells migrate into the area and swallow the oxidized LDL, transforming into bloated “foam cells” that accumulate into fatty streaks.
Over years and decades, this process builds layered plaques containing a core of dead cells and fat covered by a fibrous cap. The danger peaks when that cap becomes extremely thin. A rupture exposes the plaque’s contents to the bloodstream, triggering a blood clot that can block the artery entirely. This is the mechanism behind most heart attacks and many strokes. Elevated LDL alone, without any other risk factor, can be a sufficient cause of atherosclerosis. Familial hypercholesterolemia demonstrates this clearly: people with the condition develop heart disease at young ages purely from lifelong high LDL exposure.
Why It Usually Has No Symptoms
Dyslipidemia is often called a “silent” condition because abnormal lipid levels produce no sensation. You cannot feel high LDL or low HDL. The damage accumulates invisibly over years, which is why routine blood testing is the only reliable way to detect it.
In severe cases, particularly inherited forms, physical signs can appear. Xanthomas are yellowish fatty deposits that form under the skin, often on the tendons of the hands, elbows, or Achilles tendon. Corneal arcus is a white or grayish ring that forms around the iris. In people under 60, it can signal very high cholesterol. However, many people with genetic dyslipidemia never develop these visible signs, sometimes remaining unaware of their condition until they or a close relative has a heart attack at a young age.
The Numbers That Define It
Treatment goals for LDL cholesterol depend on your overall cardiovascular risk, not just the number on the lab report. For adults at borderline or intermediate risk (roughly a 3% to 10% chance of a cardiovascular event over the next 10 years), guidelines from the American College of Cardiology and American Heart Association target LDL below 100 mg/dL. For higher-risk individuals who have never had a cardiovascular event, the goal drops to below 70 mg/dL. For people who already have established heart disease, especially those at very high risk of another event, the target is below 55 mg/dL.
For children and adolescents, the thresholds are different. An LDL below 110 mg/dL is considered acceptable, while 130 mg/dL or above is abnormal. Total cholesterol above 200 mg/dL and triglycerides above 130 mg/dL (for ages 10 to 19) are also flagged as abnormal. HDL below 40 mg/dL is considered low regardless of age.
The Pancreatitis Risk From Very High Triglycerides
While cholesterol is the bigger concern for heart disease, triglycerides carry their own distinct danger at very high levels. When triglycerides exceed 1,000 mg/dL, the risk of acute pancreatitis (a sudden, painful inflammation of the pancreas) reaches about 10%. Above 5,000 mg/dL, the risk climbs past 50%. Below 1,000 mg/dL, triglyceride-induced pancreatitis is unlikely. This is a separate concern from the gradual cardiovascular damage and requires more urgent management.
How Dyslipidemia Is Managed
Lifestyle changes form the foundation of treatment for all types of dyslipidemia. Reducing saturated fat and trans fat intake, increasing physical activity, losing excess weight, and limiting alcohol all improve lipid levels. These steps can be enough on their own for people at lower cardiovascular risk.
When lifestyle changes are insufficient, or when risk is high enough to warrant immediate treatment, statins are the first-line medication. Statins work by reducing the liver’s production of cholesterol, which forces the liver to pull more LDL out of the bloodstream. For people who need further LDL lowering beyond what statins achieve, several add-on options exist. One blocks cholesterol absorption in the intestine. Another class, injectable medications given every two to four weeks, prevents the liver from breaking down its own LDL receptors, dramatically increasing LDL clearance. A newer oral option reduces cholesterol production through a different pathway than statins and is sometimes used by people who cannot tolerate statins.
The intensity of treatment scales with risk. Someone with mildly elevated cholesterol and no other risk factors might need only dietary changes. Someone with familial hypercholesterolemia and existing heart disease may need multiple medications to push LDL below 55 mg/dL. The goal is always to reduce LDL exposure over time, because the cumulative years of elevated LDL are what determine plaque burden and cardiovascular risk.